Evidence map›Paper›PMID 27497847›Full record

ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2017

Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia.

Nilesh Mathuria, Geru Wu, Francia Rojas-Delgado, Mossaab Shuraih, Mehdi Razavi, Andrew Civitello, Leo Simpson, Guilherme Silva, Suwei Wang, MacArthur Elayda and 4 more

Abstract readControlled Clinical Trial
PubMed Publisher
In one paragraph

Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 5 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 5 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. Preemptive mechanical circulatory support in ventricular tachycardia ablation: A systematic review and meta-analysis.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Pooled it
  2. Pooled it
  3. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: Executive summary.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2020
    Pooled it
  4. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2020
    Pooled it
  5. Percutaneous ventricular assist device in ventricular tachycardia ablation: a systematic review and meta-analysis.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2019
    Pooled it
  6. Article
  7. Review
  8. Impacts of Hemodynamic Support on Ventricular Arrhythmia Ablation.Journal of cardiovascular electrophysiology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Ventricular arrhythmias in acute heart failure: a clinical consensus statement of the Association for Acute CardioVascular Care, the European Heart Rhythm Association, and the Heart Failure Association of the European Society of Cardiology.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  14. Article
  15. Article
  16. Percutaneous mechanical support in catheter ablation of ventricular arrhythmias: hype or hope?Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Review
  17. Acute haemodynamic decompensation in the era of substrate-based ablation: rare but still worrisome.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  18. Periprocedural acute haemodynamic decompensation during substrate-based ablation of scar-related ventricular tachycardia: a rare and unpredictable event.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  19. Management of patients with an electrical storm or clustered ventricular arrhythmias: a clinical consensus statement of the European Heart Rhythm Association of the ESC-endorsed by the Asia-Pacific Heart Rhythm Society, Heart Rhythm Society, and Latin-American Heart Rhythm Society.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Nilesh MathuriaDivision of Cardiology, Baylor St. Luke's Medical Center/Texas Heart Institute, PO Box 20345, Houston, TX, 77225-0345, USA. nimathuria@texasheart.org.ORCID http://orcid.org/0000-0003-0721-6827
Geru WuDivision of Cardiology, Baylor St. Luke's Medical Center/Texas Heart Institute, PO Box 20345, Houston, TX, 77225-0345, USA.
Francia Rojas-DelgadoDivision of Cardiology, Baylor St. Luke's Medical Center/Texas Heart Institute, PO Box 20345, Houston, TX, 77225-0345, USA.
Mossaab ShuraihDivision of Cardiology, Baylor St. Luke's Medical Center/Texas Heart Institute, PO Box 20345, Houston, TX, 77225-0345, USA.
Mehdi RazaviDivision of Cardiology, Baylor St. Luke's Medical Center/Texas Heart Institute, PO Box 20345, Houston, TX, 77225-0345, USA.
Andrew CivitelloDivision of Cardiology, Baylor St. Luke's Medical Center/Texas Heart Institute, PO Box 20345, Houston, TX, 77225-0345, USA.
Leo SimpsonDivision of Cardiology, Baylor St. Luke's Medical Center/Texas Heart Institute, PO Box 20345, Houston, TX, 77225-0345, USA.
Guilherme SilvaDivision of Cardiology, Baylor St. Luke's Medical Center/Texas Heart Institute, PO Box 20345, Houston, TX, 77225-0345, USA.
Suwei WangDivision of Biostatistics, Baylor St. Luke's Medical Center/Texas Heart Institute, Houston, TX, USA.
MacArthur ElaydaDivision of Biostatistics, Baylor St. Luke's Medical Center/Texas Heart Institute, Houston, TX, USA.
Bharat KanthariaUniversity of Texas Health Science Center at Houston, Houston, TX, USA.
Steve SinghDivision of Cardiovascular Surgery, Baylor College of Medicine/Texas Heart Institute, Houston, TX, USA.
O H FrazierDivision of Cardiovascular Surgery, Baylor College of Medicine/Texas Heart Institute, Houston, TX, USA.
Jie ChengDivision of Cardiology, Baylor St. Luke's Medical Center/Texas Heart Institute, PO Box 20345, Houston, TX, 77225-0345, USA.
Texas Medical Center · USBaylor College of Medicine · USThe University of Texas Health Science Center at Houston · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePatient selection and timing of percutaneous left ventricular assist device (pLVAD) insertion for maximal benefit during ventricular tachycardia (VT) ablation is not well defined. We aimed to assess the outcomes of pre-emptive and rescue use of pLVAD during VT ablation in patients with ischemic and non-ischemic cardiomyopathy.

methodsBetween January 2009 and October 2011, 93 patients underwent VT ablation. Three groups were compared: (1) Rescue group (n = 12)-patients who required emergent pLVAD insertion due to hemodynamic collapse during VT ablation, (2) Pre-emptive group (n = 24)-patients who had pre-ablation pLVAD insertion, and (3) Non-pLVAD group (n = 57)-patients who did not undergo pLVAD insertion. Procedural outcomes including 30-day mortality were compared.

resultsThirty-day mortality was higher in the Rescue group compared to the Pre-emptive group (58 vs. 4 %, p = 0.003) and non-pLVAD (58 vs. 3 %, p = 0.001) group. There was no significant difference in 30-day mortality or long-term freedom of VT between the pre-emptive and non-pLVAD groups.

conclusionsDespite rescue pLVAD insertion, hemodynamic collapse during VT ablation is associated with a persistently high 30-day mortality. Further studies are warranted to predict hemodynamic collapse and to refine the role of pLVAD in this setting.

Indexed as

AgedCardiomyopathiesCatheter AblationCombined Modality TherapyComorbidityEmergency Medical ServicesFemaleHeart-Assist DevicesHumansIncidenceMaleMiddle AgedPatient SelectionRisk FactorsSurvival RateTachycardia, VentricularAblationCardiomyopathyPercutaneous left ventricular assist deviceVentricular tachycardia

Identifiers

PMID27497847
OpenAlexW2494598108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.